title: [Electroretinography in the diagnosis and monitoring of treatment for neovascular age-related macular degeneration: Communication 2].
abstract: Electroretinography is an informative tool in evaluating retinal function in age-related macular degeneration (ARMD) and in monitoring the treatment of choroidal neovascularization (CNV). The review gives the results of electroretinographic studies in the monitoring of CNV, by using photodynamic therapy (PDT) and angiostatic agents and in combined PDT and anti-VEGF therapy. The regularities of retinal functional changes in the early and late periods after mono- and combined therapy are considered. The informative value of various electroretinographic studies was compared in the evaluation of retinal functional changes after therapy and in the prediction of its efficiency. Multifocal electroretinography is today of the greatest value among other conventional methods; however, there is a need for searching for new objective indicators that enable assessment of progress in the treatment of neovascular ARMD and optimization of indications for this or that treatment, particularly when new and expensive technologies of treating CNV emerge.
authors.forename: M V
authors.initials: MV
authors.lastname: Zueva
authors.forename: I V
authors.initials: IV
authors.lastname: Tsapenko
authors.forename: M V
authors.initials: MV
authors.lastname: Riabina
authors.forename: M I
authors.initials: MI
authors.lastname: Grinchenko
authors.forename: N V
authors.initials: NV
authors.lastname: Neroeva
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D003937:Diagnosis, Differential; D004596:Electroretinography / Q000379:methods*; D006801:Humans; D008268:Macular Degeneration / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D008991:Monitoring, Physiologic / Q000379:methods*; D010778:Photochemotherapy / Q000379:methods*; D011379:Prognosis; D012160:Retina / Q000503:physiopathology*
chemical_list: D020533:Angiogenesis Inhibitors